EGFR and triple-negative breast carcinoma: Different coating proteins may serve to target othercancers like in the case of heregulin-modified protein directed atthe human epidermal growth factor receptor (HER), which in combinationof the gallium complex of a sulfonated corrole was proven very effectivein the case of triple negative breast cancer.34 The current paradigm of precision medicine could be achieved withrelative ease, considering the simplicity of the formulation and encapsulation-targetingligand.